Not a great 4th quarter, down 10% in USD terms yoy, with international being down 15%, but it does complete the picture as regards AUD full year sales.
This now generates AUD FY16 sales of 205.3 v FY15 sales of 192.5, being a 7% increase. Not a bad result given the TST hangover and overall low growth global scenario.
This should result in EPS in the region of 9c and bode well for a dividend in the 6-8 cent range, which should support the current valuation and also excludes any non Axiron revenue, which is not insignificant.
a 6c divvy on 85c is still a net dividend of 7.1% derived on USD sales. Not to be sniffed at.
[using qty average exchange rates which are only a proxy for the actual company translation policy]
- Forums
- ASX - By Stock
- ACR
- FY16 AUD Revenue +7%
FY16 AUD Revenue +7%
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.89M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3903 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3903 | 0.062 |
2 | 116666 | 0.060 |
1 | 17200 | 0.058 |
2 | 167543 | 0.057 |
2 | 67857 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 100000 | 1 |
0.065 | 70395 | 1 |
0.070 | 50000 | 1 |
0.072 | 47301 | 1 |
0.073 | 30000 | 3 |
Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
ACR (ASX) Chart |
Day chart unavailable